SPEVIGO 150 mg/1ml sol inj 150 mg 2 pce
7680695790016
CH-69579
L04AC22
07.15.0.
1 / 3
google
Details
- Product number
- 6957901
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- spesolimabum 150 mg, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s., ad solutionem pro 1 ml, natrium 0.91 mg.
Articles (1)
Spevigo 150 mg/1ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.91 MG | Substance | HBESI |
Authorization holder
Boehringer Ingelheim (Schweiz) GmbH
4057 Basel
Authorization information
- Swissmedic authorization number
- 69579
- Drug name
- Spevigo, Injektionslösung in einer Fertigspritze
- Galenic form
- INFFS
- ATC Code
- L04AC22
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/05/2025
- Authorization expiration date
- 27/05/2030
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SPEVIGO 150 mg/1ml sol inj 150 mg 2 pce
- Description (DE)
- SPEVIGO 150 mg/1ml Inj Lös 150 mg 2 Stk
- Market launch
- 01/02/2026
- Narcotic (BTM)
- No